What Savara Investors Should Know About 580K Options
Savara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
Knowing what percentages to allocate to stocks and bonds helps in portfolio balance. Learn effective allocation strategies today.
28,656 articlesSavara investors should stay focused on how insider moves and regulatory timelines interact with a growing biotech st...
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Could canopy growth stock realistically quadruple from here? This deep-dive walks through the bull case, the risks, a...
Powell Industries stock soars after a significant stake increase by a prominent fund, driving a 161% annual gain. Thi...
Stock splits can make a popular stock feel more approachable, but they don’t change the business. Read on to see how ...
With Broadcom set to report earnings, investors are weighing momentum in AI infrastructure against valuation. This gu...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
Qualcomm nudges the industry toward 6G with a bold roadmap. Investors are weighing the potential for faster networks ...
Rivian just raised guidance, signaling progress in its production ramp. Yet the stock reaction was bearish, underscor...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
In February, Occidental Petroleum’s stock surged nearly 17%, powered by higher oil prices and strong earnings signals...